why choose us

First received: June 29, 2023

Clinical Trial: Safety and Efficacy of MBF-118 in Patients with Crohn Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Crohn Disease

Study Type: INTERVENTIONAL


Official Title: A Phase IIa, Open Label, Single-centre Study to Assess the Initial Antifibrotic Efficacy, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of MBF-118 in Crohn's Disease Patients

Brief Summary: This is a Phase IIa (proof of concept), single center clinical trial to evaluate the safety and efficacy of daily MBF-118 oral treatment during 28 days in Crohn's disease patients on top of standard of care.

Read more